赤天化(hua)25日晚公(gong)告,預計公(gong)司(si)(si)2017年(nian)(nian)度(du)實(shi)現(xian)(xian)歸屬(shu)(shu)于(yu)(yu)上(shang)市公(gong)司(si)(si)股(gu)東的(de)(de)凈(jing)利(li)潤(run)與上(shang)年(nian)(nian)同(tong)期相比,將實(shi)現(xian)(xian)扭虧為盈(ying),實(shi)現(xian)(xian)歸屬(shu)(shu)于(yu)(yu)上(shang)市公(gong)司(si)(si)股(gu)東的(de)(de)凈(jing)利(li)潤(run)為3,000萬(wan)(wan)到(dao)(dao)6,000萬(wan)(wan)元(yuan)。預計歸屬(shu)(shu)于(yu)(yu)上(shang)市公(gong)司(si)(si)股(gu)東扣除非經常性損(sun)益后(hou)的(de)(de)凈(jing)利(li)潤(run)為-5,000萬(wan)(wan)元(yuan)到(dao)(dao) -2,000萬(wan)(wan)元(yuan)。上(shang)年(nian)(nian)同(tong)期歸屬(shu)(shu)于(yu)(yu)上(shang)市公(gong)司(si)(si)股(gu)東的(de)(de)凈(jing)利(li)潤(run):-34,953.42萬(wan)(wan)元(yuan)。
報(bao)告期內,公(gong)(gong)司(si)尿素、甲醇等(deng)主導產(chan)品市場價(jia)(jia)格呈現(xian)回曖趨勢,產(chan)品價(jia)(jia)格較上期同比有所上升,公(gong)(gong)司(si)化工業務實(shi)現(xian)減虧。醫(yi)藥(yao)產(chan)品銷量實(shi)現(xian)增長。本次業績(ji)預告期間,公(gong)(gong)司(si)確認對(dui)原控股(gu)子公(gong)(gong)司(si)康心藥(yao)業的(de)股(gu)權(quan)處(chu)置收益(yi),實(shi)現(xian)非經常性損益(yi)約5,200萬元(yuan)。此外,公(gong)(gong)司(si)在業績(ji)預告期確認其他非經常性損益(yi)(違(wei)約金(jin)等(deng))共計約2,800萬元(yuan)。